Past project.

Cannabis Product Development & Drug Delivery Innovation

Cannadips

Problem
Need for differentiated cannabinoid delivery systems and regulatory approval for higher-dose formats.

Solution
Served as scientific advisor on formulation and delivery technologies.

Strategy

●      Developed oral mucosal delivery systems

●      Designed dose standardization and bioavailability strategies

●      Guided regulatory submission (CDPH higher-dose qualification)

●      Assisted with formulations and patent applications

●      Provided a scientific rationale to support market adoption of CBD product line as distinguished from THC for a national retail chain

Outcome / Impact

●      Achieved regulatory approval for higher-dose products

●      Enabled product differentiation in competitive market

Previous
Previous

EU-GMP / GACP Compliance Implementation

Next
Next

IVD Platform Development & FDA Regulatory Strategy